Cargando…
Pimavanserin for the treatment of psychosis in Alzheimer’s disease: A literature review
BACKGROUND: Alzheimer’s disease (AD) is among the most prevalent forms of dementia in the world and neuropathological studies suggest similar high prevalence of mixed (AD + vascular) dementias. Approximately 25%-50% of individuals with AD develop psychosis sometime during their illness. The presence...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7418577/ https://www.ncbi.nlm.nih.gov/pubmed/32844093 http://dx.doi.org/10.5498/wjp.v10.i7.162 |